HOPA Keynote Speaker Addresses Structural Racism in Pharmacy
April 14th 2021Lakesha M. Butler, PharmD, BCPS, diversity and inclusion coordinator and clinical professor at Southern Illinois University Edwardsville, discussed causes of health inequity and how pharmacists can prevent and mitigate them to improve patient outcomes.
Read More
Prophylactic Approach to Cancer-Related Thrombosis May Be Optimal
April 14th 2021Even while therapeutically anticoagulated, patients with cancer have risk factors for recurring venous thromboembolism and bleeding, according to a session at the Hematology/Oncology Pharmacy Association 2021 Virtual Annual Conference.
Read More
Sacituzumab Govitecan Granted Accelerated Approval for Advanced Urothelial Cancer
April 14th 2021Sacituzumab govitecan (Trodelvy) approved for patients with locally advanced or metastatic urothelial cancer who previously received a platinum-containing chemotherapy and either a PD-1 or PD-L1 inhibitor.
Read More
HOPA 2021: New Therapies on the Horizon for Advanced NSCLC
April 13th 2021A session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.
Read More
Johnson & Johnson, AstraZeneca COVID-19 Vaccines Share Concerns About Rare Blood Clots
April 13th 2021As the FDA and CDC have paused use of the Johnson & Johnson COVID-19 vaccine in the United States, research is ongoing to understand whether cerebral venous sinus thrombosis (CVST) is directly linked to the vaccine.
Watch
Three Major Studies Alter the Practice of Treating Gastroesophageal Carcinomas
April 12th 2021A presentation at the Community Oncology Alliance 2021 Virtual Conference focused on the latest developments in gastrointestinal oncology and how the field of gastroesophageal cancer is responding to 3 major, practice-changing trials.
Read More
How Pharmacists Can Protect Patients from Outdated COVID-19 Treatment
April 12th 2021The pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.
Read More
Artificial Intelligence Identifies Novel Multiple Sclerosis Subtypes
April 12th 2021A new study published in Nature Communications used artificial intelligence (AI) to identify 3 new multiple sclerosis (MS) subtypes, which may help identify which individuals are more likely to have disease progression, according to the authors.
Read More
Choice of Blood Pressure Medications Impacts Long-Term Heart Disease Risk in Patients With HIV
April 12th 2021Among patients with HIV who had not been diagnosed with heart disease at the beginning of the study, the risk of developing heart disease, heart failure, or stroke for the first time was 90% higher among those taking beta-blockers.
Read More